Azetidinecarboxamide derivatives for treating CNS disorders
US6403574B1 · kind B1 · utility
4Cited by
1References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 17, 2001 |
| Grant date | Jun 11, 2002 |
| Priority date | — |
| Expiry date | Sep 17, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound of formula (1), wherein: R1 is aryl; R2 is H, alkyl or aryl; and R3 is hydrogen or alkyl; pharmaceutically acceptable addition compounds thereof; and the use of the compounds in therapy, particularly for the treatment and prophylaxis of CNS disorders such as anxiety and epilepsy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.